Sin DD - Search Results

1

Pharmacotherapy considerations for morning symptoms in chronic obstructive pulmonary disease.

Leung C, Sin DD. Leung C, et al. Among authors: sin dd. Expert Opin Pharmacother. 2022 Aug;23(12):1359-1362. doi: 10.1080/14656566.2022.2116274. Epub 2022 Aug 24. Expert Opin Pharmacother. 2022. PMID: 35986503 No abstract available.

2

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.

Sin DD, Lacy P, York E, Man SF. Sin DD, et al. Am J Respir Crit Care Med. 2004 Oct 1;170(7):760-5. doi: 10.1164/rccm.200404-543OC. Epub 2004 Jun 30. Am J Respir Crit Care Med. 2004. PMID: 15229100 Clinical Trial.

3

Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis.

Gan WQ, Man SF, Sin DD. Gan WQ, et al. Among authors: sin dd. BMC Pulm Med. 2005 Feb 11;5:3. doi: 10.1186/1471-2466-5-3. BMC Pulm Med. 2005. PMID: 15707484 Free PMC article. Review.

4

Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?

Man SF, Sin DD. Man SF, et al. Among authors: sin dd. Drugs. 2005;65(5):579-91. doi: 10.2165/00003495-200565050-00001. Drugs. 2005. PMID: 15748094 Review.

5

Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.

Sin DD, Man SF. Sin DD, et al. Can J Physiol Pharmacol. 2005 Jan;83(1):8-13. doi: 10.1139/y04-116. Can J Physiol Pharmacol. 2005. PMID: 15759045 Review.

6

Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality.

Sin DD, Man SF. Sin DD, et al. Proc Am Thorac Soc. 2005;2(1):8-11. doi: 10.1513/pats.200404-032MS. Proc Am Thorac Soc. 2005. PMID: 16113462 Review.

7

Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease.

Man SF, Sin DD. Man SF, et al. Among authors: sin dd. Proc Am Thorac Soc. 2005;2(1):78-82. doi: 10.1513/pats.200406-034MS. Proc Am Thorac Soc. 2005. PMID: 16113473 Review.

8

Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].

Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, Wilde E, Cowie RL, Williams D, Rousseau R; ABC (Advair, Biomarkers in COPD) Investigators. Sin DD, et al. BMC Pulm Med. 2006 Feb 6;6:3. doi: 10.1186/1471-2466-6-3. BMC Pulm Med. 2006. PMID: 16460562 Free PMC article. Clinical Trial.

9

Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Gan WQ, Man SF, Postma DS, Camp P, Sin DD. Gan WQ, et al. Among authors: sin dd. Respir Res. 2006 Mar 29;7(1):52. doi: 10.1186/1465-9921-7-52. Respir Res. 2006. PMID: 16571126 Free PMC article.

10

Emerging drugs for the treatment of chronic obstructive pulmonary disease.

Malhotra S, Man SF, Sin DD. Malhotra S, et al. Among authors: sin dd. Expert Opin Emerg Drugs. 2006 May;11(2):275-91. doi: 10.1517/14728214.11.2.275. Expert Opin Emerg Drugs. 2006. PMID: 16634702 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

644 results

Search Page

Filters